Glen Harbor Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Glen Harbor Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$201K	Hold	2,754	–	–	﹤0.01%	1010
2019 Q2	$226K	Hold	2,754	–	–	﹤0.01%	982
2019 Q1	$194K	Hold	2,754	–	–	﹤0.01%	1001
2018 Q4	$124K	Hold	2,754	–	–	﹤0.01%	1080
2018 Q3	$156K	Buy	2,754 +578	+27%	+$35.4K	﹤0.01%	1124
2018 Q2	$145K	Hold	2,176	–	–	﹤0.01%	1068
2018 Q1	$127K	Hold	2,176	–	–	﹤0.01%	1099
2017 Q4	$140K	Buy	2,176 +306	+16%	+$19K	﹤0.01%	1084
2017 Q3	$98K	Buy	1,870 +306	+20%	+$14.6K	﹤0.01%	1126
2017 Q2	$73K	Buy	1,564 +884	+130%	+$42.6K	﹤0.01%	1150
2017 Q1	$34K	Buy	+680	New	+$38.2K	﹤0.01%	1186

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Glen Harbor Capital Management's ANIP Position: Q3 2019 in Review

Glen Harbor Capital Management held its ANI Pharmaceuticals (ANIP) position steady in Q3 2019 at 2,754 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Glen Harbor Capital Management first reported a position in ANIP in Q1 2017 and has held it in 11 quarters since. The position peaked at $226K in Q2 2019. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

Glen Harbor Capital Management held 2,754 shares of ANI Pharmaceuticals worth $201K as of Q3 2019.
Glen Harbor Capital Management left its ANI Pharmaceuticals share count unchanged in Q3 2019.
ANI Pharmaceuticals made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1010 holding.
Glen Harbor Capital Management first reported a position in ANI Pharmaceuticals in Q1 2017 and has held it in 11 quarters since.
Glen Harbor Capital Management's ANI Pharmaceuticals position peaked at $226K in Q2 2019.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.